BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1281806)

  • 1. Acidic mucin in the prostate: can it differentiate adenosis from adenocarcinoma?
    Epstein JI; Fynheer J
    Hum Pathol; 1992 Dec; 23(12):1321-5. PubMed ID: 1281806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosis of the prostate. Histologic features in needle biopsy specimens.
    Gaudin PB; Epstein JI
    Am J Surg Pathol; 1995 Jul; 19(7):737-47. PubMed ID: 7793471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucin histochemistry in primary adenocarcinoma of the urinary bladder (of urachal or vesicular origin) and metastatic adenocarcinoma originating in the colorectum.
    Nakanishi K; Tominaga S; Kawai T; Torikata C; Aurues T; Ikeda T
    Pathol Int; 2000 Apr; 50(4):297-303. PubMed ID: 10849315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucin expression in atypical adenomatous hyperplasia of the prostate.
    Goldstein NS; Qian J; Bostwick DG
    Hum Pathol; 1995 Aug; 26(8):887-91. PubMed ID: 7543443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of cytokeratin 5/6 as an effective substitute for keratin 903 in the differentiation of benign from malignant glands in prostate needle biopsies.
    Abrahams NA; Ormsby AH; Brainard J
    Histopathology; 2002 Jul; 41(1):35-41. PubMed ID: 12121235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerosing adenosis of the prostate gland. A clinicopathological and immunohistochemical study of 11 cases.
    Jones EC; Clement PB; Young RH
    Am J Surg Pathol; 1991 Dec; 15(12):1171-80. PubMed ID: 1720930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerosing adenosis of the prostate. Histopathologic and immunohistochemical analysis.
    Sakamoto N; Tsuneyoshi M; Enjoji M
    Am J Surg Pathol; 1991 Jul; 15(7):660-7. PubMed ID: 1711794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small glandular proliferations on needle biopsies: most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion.
    Herawi M; Parwani AV; Irie J; Epstein JI
    Am J Surg Pathol; 2005 Jul; 29(7):874-80. PubMed ID: 15958851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
    Chen YB; Fine SW; Epstein JI
    Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases.
    Wojno KJ; Epstein JI
    Am J Surg Pathol; 1995 Mar; 19(3):251-60. PubMed ID: 7532918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sclerosing adenosis of the prostate. Carcinoma simulation].
    Meister P
    Pathologe; 1996 Mar; 17(2):157-62. PubMed ID: 8650147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing Cowper's glands from neoplastic and pseudoneoplastic lesions of prostate: immunohistochemical and ultrastructural studies.
    Saboorian MH; Huffman H; Ashfaq R; Ayala AG; Ro JY
    Am J Surg Pathol; 1997 Sep; 21(9):1069-74. PubMed ID: 9298883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical evaluation of TMPRSS2-ERG gene fusion in adenosis of the prostate.
    Green WM; Hicks JL; De Marzo A; Illei PP; Epstein JI
    Hum Pathol; 2013 Sep; 44(9):1895-901. PubMed ID: 23664537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of alpha-methylacyl coenzyme A racemase immunohistochemistry in the diagnosis of prostate cancer: a review.
    Adley BP; Yang XJ
    Anal Quant Cytol Histol; 2006 Feb; 28(1):1-13. PubMed ID: 16566275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis of glandular proliferations in the prostate. A conventional and immunohistochemical approach.
    Helpap B
    Virchows Arch; 1998 Nov; 433(5):397-405. PubMed ID: 9849853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
    Osunkoya AO; Epstein JI
    Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerosing adenosis of the prostate. Histologic features in needle biopsy specimens.
    Luque RJ; Lopez-Beltran A; Perez-Seoane C; Suzigan S
    Arch Pathol Lab Med; 2003 Jan; 127(1):e14-6. PubMed ID: 12562286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid mucin and high molecular weight cytokeratin in prostatic lesions: evaluation of a combined histochemical and immunohistochemical stain.
    Gal R; Halpern M; Koren R; Rath-Wolfson L; Klein B; Siegal A
    Br J Urol; 1995 Jul; 76(1):57-60. PubMed ID: 7544206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reappraisal of orthodox histochemistry for the diagnosis of minimal deviation adenocarcinoma of the cervix.
    Hayashi I; Tsuda H; Shimoda T
    Am J Surg Pathol; 2000 Apr; 24(4):559-62. PubMed ID: 10757403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate.
    Shah IA; Schlageter MO; Stinnett P; Lechago J
    Mod Pathol; 1991 Mar; 4(2):220-4. PubMed ID: 1710806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.